HDAC AND PI3K ANTAGONISTS COOPERATE TO INHIBIT GROWTH OF MYC-DRIVEN MEDULLOBLASTOMA

被引：0
|
作者：
Liu, Kun-Wei [1 ]
Pei, Yanxin [1 ,2 ]
Wechsler-Reya, Robert [1 ]
机构：
[1] Sanford Burnham Med Res Inst, La Jolla, CA USA
[2] Childrens Natl Med Ctr, Washington, DC 20010 USA
来源：
NEURO-ONCOLOGY | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MB-13
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [31] Sensing and Integration of Erk and PI3K Signals by Myc
    Lee, Tae
    Yao, Guang
    Nevins, Joseph
    You, Lingchong
    PLOS COMPUTATIONAL BIOLOGY, 2008, 4 (02)
  • [32] PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth
    Sharma, Narinder
    Nanta, Rajesh
    Sharma, Jay
    Gunewardena, Sumedha
    Singh, Karan P.
    Shankar, Sharmila
    Srivastava, Rakesh K.
    ONCOTARGET, 2015, 6 (31) : 32039 - 32060
  • [33] The expression of PI3K, AKT and Nrf-2 in medulloblastoma
    Xiao, L.
    Yu, L.
    HISTOPATHOLOGY, 2010, 57 : 207 - 207
  • [34] Targeting the PI3K/AKT/mTOR Signaling Pathway in Medulloblastoma
    Dimitrova, V.
    Arcaro, A.
    CURRENT MOLECULAR MEDICINE, 2015, 15 (01) : 82 - 93
  • [35] MYC-DRIVEN UPREGULATION OF THE DE NOVO SERINE AND GLYCINE PATHWAY IS A NOVEL THERAPEUTIC TARGET FOR GROUP 3 MYC-AMPLIFIED MEDULLOBLASTOMA
    Adiamah, Magretta
    Lindsey, Janet C.
    Burte, Florence
    Kohe, Sarah
    Morcavallo, Alaide
    Blair, Helen
    Hill, Rebecca M.
    Singh, Mankaran
    Crosier, Stephen
    Zhang, Tong
    Maddocks, Oliver
    Peet, Andrew
    Chesler, Louis
    Hickson, Ian
    Maxwell, Ross
    Clifford, Steven C.
    NEURO-ONCOLOGY, 2022, 24 : 125 - 125
  • [36] Dual Targeting of PI3K and HDAC by CUDC-907 Inhibits Pediatric Neuroblastoma Growth
    Chilamakuri, Rameswari
    Agarwal, Saurabh
    CANCERS, 2022, 14 (04)
  • [37] Apigenin and Temozolomide Synergistically Inhibit Glioma Growth Through the PI3K/AKT Pathway
    Wang, Dong
    Wang, Zhijun
    Dai, Xuedong
    Zhang, Liang
    Li, Min
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (02) : 125 - 132
  • [38] The Novel CDK9/CDK4/6/PI3K Triple Inhibitor LCI139 for the Treatment of MYC-Driven Mantle Cell Lymphoma
    Pal, Dhananjaya
    Arditti, Page Mangum
    Maddeboina, Krishnaiah
    McHale, Cody C.
    Yang, Hsih-Te
    Yada, Bharath
    Dryden, Hailey Lynn
    Foureau, David M.
    Durden, Donald L.
    BLOOD, 2023, 142
  • [39] TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma
    Maynard, Rachael E.
    Poore, Brad
    Hanaford, Allison R.
    Pham, Khoa
    James, Madison
    Alt, Jesse
    Park, Youngran
    Slusher, Barbara S.
    Tamayo, Pablo
    Mesirov, Jill
    Archer, Tenley C.
    Pomeroy, Scott L.
    Eberhart, Charles G.
    Raabe, Eric H.
    CANCER LETTERS, 2021, 504 : 137 - 145
  • [40] Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis
    Sander, Sandrine
    Calado, Dinis P.
    Srinivasan, Lakshmi
    Koechert, Karl
    Zhang, Baochun
    Rosolowski, Maciej
    Rodig, Scott J.
    Holzmann, Karlheinz
    Stilgenbauer, Stephan
    Siebert, Reiner
    Bullinger, Lars
    Rajewsky, Klaus
    CANCER CELL, 2012, 22 (02) : 167 - 179
12345